For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Visen Medical, Inc.

USPTO Granted Patents = 39

CIPO Patents = 1

EPO Patents = 24

Trademarks = 8

Forward Citations = 319

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Milind Rajopadhye (14 out of 43 patents)

Kevin Groves (11 out of 15 patents)

Wael I Yared (10 out of 14 patents)

4. Narasimhachari Narayanan (9 out of 18 patents)

5. Joshua Kempner (8 out of 8 patents)

6. Jorge Ripoll Lorenzo (4 out of 7 patents)

7. Jeffrey D Peterson (4 out of 5 patents)

8. Guojie Ho (4 out of 7 patents)

9. Vasilis Ntziachristos (3 out of 36 patents)

10. Bagna Bao (3 out of 4 patents)

11. Dorin V Preda (3 out of 9 patents)

12. Pouyan Mohajerani (3 out of 3 patents)

13. Jorge Lorenzo (3 out of 4 patents)

14. Karen Madden (3 out of 3 patents)

15. Paul J Coleman (2 out of 51 patents)

39 patents: Sort by Forward Citations

1. 12110283 - Carbonic anhydrase targeting agents and methods of using same (2024-10-08),

2. 11903675 - Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources (2024-02-20),

3. 11193932 - 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof (2021-12-07),

4. 11059802 - Carbonic anhydrase targeting agents and methods of using same (2021-07-13),

5. 10743768 - Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources (2020-08-18),

6. 10473658 - 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof (2019-11-12),

7. 10442930 - Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels (2019-10-15),

8. 10221159 - Carbonic anhydrase targeting agents and methods of using same (2019-03-05),

9. 10092188 - Methods and compositions for identifying subjects at risk of developing stent thrombosis (2018-10-09),

10. 10064584 - Combined x-ray and optical tomographic imaging system (2018-09-04),

11. 9999687 - Fluorescent imaging agents (2018-06-19),

12. 9913917 - Biocompatible fluorescent metal oxide nanoparticles (2018-03-13),

13. 9901254 - Systems and methods for virtual index-matching of diffusive media (2018-02-27),

14. 9897604 - 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof (2018-02-20),

15. 9694089 - Integrin targeting agents and in-vivo and in-vitro imaging methods using the same (2017-07-04),

VisEn Medical, Inc. is a leading provider of fluorescence imaging solutions for research and drug development. The company offers a range of innovative imaging agents, imaging systems, and software tools designed to enhance biological imaging and accelerate the discovery and development of new therapeutics. VisEn Medical's state-of-the-art technologies enable scientists and researchers to visualize, quantify, and analyze molecular events in living subjects with high sensitivity and spatial resolution. By providing accurate and detailed molecular imaging solutions, VisEn aims to facilitate breakthroughs in disease understanding and contribute to the advancement of personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#31 in Waltham, MA

#497 in Massachusetts

#8,539 in US

#16,944 in the World

Waltham, MA, United States of America

Visen Medical, Inc.

Forward Citations = 319

26 inventors:

Milind Rajopadhye (14 out of 43 patents)

Kevin Groves (11 out of 15 patents)

Wael I Yared (10 out of 14 patents)

4. Narasimhachari Narayanan (9 out of 18 patents)

5. Joshua Kempner (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…